Back
Rocket Pharmaceuticals Vs. Aldeyra Therapeutics Industry Stock Comparison
Sell
50
RCKT
Rocket Pharmaceuticals
Last Price:
23.63
Seasonality Move:
26.74%
Sell
27
ALDX
Aldeyra Therapeutics
Last Price:
3.95
Seasonality Move:
3.38%
Sell
50
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $23.63. The Score for RCKT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- RCKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $3.94. The Score for ALDX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ALDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $23.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight selling pressure.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $3.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALDX is experiencing slight buying pressure.
RCKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 39.06 | Sell |
| Chaikin Money Flow: | -278289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.78 - 26.72) | Sell |
| Bollinger Bands (100): | (25.41 - 29.55) | Sell |
ALDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 53.13 | Buy |
| Chaikin Money Flow: | 22635 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.2 - 4.38) | Buy |
| Bollinger Bands (100): | (2.97 - 3.87) | Buy |
RCKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.67 | Sell |
| 20-day SMA: | 24.75 | Sell |
| 50-day SMA: | 26.88 | Sell |
| 200-day SMA: | 23.06 | Buy |
| 8-day EMA: | 23.81 | Sell |
| 20-day EMA: | 24.67 | Sell |
| 50-day EMA: | 25.99 | Sell |
| 200-day EMA: | 24.24 | Sell |
ALDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.96 | Sell |
| 20-day SMA: | 4 | Sell |
| 50-day SMA: | 3.62 | Buy |
| 200-day SMA: | 4.49 | Sell |
| 8-day EMA: | 3.97 | Sell |
| 20-day EMA: | 3.9 | Buy |
| 50-day EMA: | 3.68 | Buy |
| 200-day EMA: | 4.42 | Sell |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and a decrease next year of $0.21 per share.
Rocket Pharmaceuticals Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aldeyra Therapeutics Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||